Cancer-elicited inflammation attenuates response and outcome in tyrosine kinase inhibitor naive patients with advanced NSCLC

Ying, HQ; Liao, YC; Luo, YR; Xiong, G; Huang, Y; Nie, RW; Xiong, CF; Cheng, XX

Cheng, XX (corresponding author), Nanchang Univ, Biol Resource Ctr, Affiliated Hosp 2, Nanchang 330006, Jiangxi, Peoples R China.

PHARMACOLOGICAL RESEARCH, 2021; 170 ():

Abstract

Objective: Cancer elicited inflammation is the main environmental cause leading to carcinogenesis and metastasis of non-small cell lung cancer (NSCLC)......

Full Text Link